All those suffering from asthma and using long-acting beta-agonist (LABA) asthma inhalers for treating asthma signs could be facing more detrimental outcome rather than benefits. Lately, the Food and Drug Administration (FDA) made an announcement regarding the new-fangled safety caveats mentioning that the drugs must not be employed on their own by kids or grownups. FDA states that it would need manufacturing companies include further caveats on their product labelling and requesting physicians and patients for scaling back general usage of the medications. Director, FDA’s Center for Drug Evaluation and Research, Dr. Janet Woodcock stated that asthmatic patients must endeavour to acquire solely a solo-agent steroid inhaler medication and not be trying to obtain combination drugs along with LABA except when it is truly an urgent requirement. FDA has pointed out that LABAs place asthmatic persons at greater chances of acute, deteriorating signs often leading to greater rates of  [...]